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Abstract: Mitochondrial genetic diseases are receiving increasing attention. However, the common case-control meth-
ods are susceptible to genetic background, population stratification, data quality and other factors that may lead to false 
positive results. The field of genetic diseases has not been paid enough attention. Therefore, this paper reviews this 
method and promotes the extensive and in-depth use of mitochondrial genetic diseases. 
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Mitochondrial genetic diseases are diseases caused by MITOCHON DRIAL DNA (mtDNA) deficiencies (includ-
ing MITOCHON DRIAL DNA deletion, insertion and point mutation) that lead to MITOCHON DRIAL dysfunction. 
Mitochondria are organelles that provide energy within cells and regulate programmed cell death. Dysfunction of the 
mitochondria can lead to a series of disorders, such as dyssynthesis of ATP and insufficient energy production. In addi-
tion to LHON (Lieber's hereditary optic atrophy), Leigh disease (subacute necrotizing encephalomyelopathy), MELAS 
(mitochondrial encephalomyopathy with lactoxemia and stroke-like attack) and MERF (muscle), which have been well 
described clinically In addition to many clinical syndromes such as clonic epilepsy with RRF, patients with mitochon-
drial dysfunction may exhibit a variety of other systemic abnormalities, such as deafness, diabetes, heart disease, tu-
mor
[1-4]
 Holt et al.
[5]
 for the first time in 1988, mitochondrial DNA deletions were found in patients with mitochondrial 
diseases, suggesting that mtDNA mutations may be severe. The cause of the disease.  
With the deepening of research on mitochondrial genetic diseases, more and more people have come to understand 
the role of mtDNA in diseases. However, there are also some problems in this field, mainly as follows: (1) ignoring the 
ancestral variation of mtDNA itself, that is, maternal genetic background, is easy to mutate on mtDNA. Isolated views 
often lead to false positive results or inaccurate inferences or even incorrect conclusions. Current studies of mitochon-
drial genetic diseases usually use case-control methods of association analysis, i. e. comparing mtDNA mutations be-
tween patients and normal controls to identify possible mutations. However, because the mitochondrial genome is a 
non-recombinant molecule, all mutation sites are tightly linked. A simple case-control analysis without taking into ac-
count the entire variation pattern of the haplotype to which the mutation belongs may treat other mutation sites closely 
linked to the pathogenic mutation as pathogenic mutations, thus obtaining false positive results. Results. For example, 
many mtDNA mutations previously thought to be associated with disease or longevity are actually characteristic muta-
tions in some lineages
[6–8]
. Statistically significant differences exist between groups, and this mutation is often thought 
to be associated with disease occurrence, but this method is very vulnerable to the effect of population stratification 
resulting in false positive results. Population stratification is more complicated by recombinant, wholly linked mole-
cules. Different subpopulations within a population may belong to different mtDNA lineages, carrying different charac-
teristic mutation sites, and even patients from the same region and normal controls may belong to different mtDNA lin-
eages. For normal controls, the characteristic variation in the accumulation of mtDNA in the patient's lineage itself  
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may be mistaken for a pathogenic mutation. For this reason, many mtDNA mutations associated with disease obtained 
from case-control methods are often difficult to replicate in studies of different populations. In recent years, more and 
more mtDNA sequences have been obtained, but unfortunately, due to the lack of strict quality control measures, the 
reported mtDNA sequence data in this field often have one or more problems and errors, leading to serious data quality 
problems in mitochondrial genetic diseases. This also has some doubts about its findings or inferences
[11–13]
. 
In view of the above problems, phylogenetic analysis should be recommended: under the guidance of reconstruct-
ed mtDNA phylogenetic relationships, the maternal genetic structure of the subjects should be assessed first, and then 
the combination of phylogenetic knowledge can help to identify characteristic mutation sites and potential pathogenic 
mutations, thus avoiding erroneous conclusions. This paper reviews the application of phylogenetic analysis in mito-
chondrial genetic diseases, hoping to be helpful to the study of mitochondrial genetic diseases in China.  
1. The concept of phylogenetic relationship of 1mtDNA 
The phylogeny is relative to ontogeny. It refers to the formation and development of a certain group. Each group 
has its own history of development, so what is the evolutionary relationship between different groups? To explore this 
problem is to study the phylogeny of different groups. The origin and evolutionary relationship of population, that is, 
reconstructing the phylogenetic relationship of the world population, is a very important part of evolutionary biology, 
and has attracted more and more attention. 
Human mtDNA is a ring-closed molecule. Because of its strict maternal inheritance and no recombination, a 
mtDNA genome corresponds to haplotype. In a maternal-radiated mtDNA haplotype lineage, mutations in the mito-
chondrial genome originate purely from the sequential accumulation of new mutations. In addition, all mutations can be 
faithfully and continuously inherited along the maternal line, so there is theoretically a temporal sequence of all muta-
tions accumulated in a mtDNA lineage. After the population spread to different areas, the mtDNA lineages in the popu-
lation still accumulate and mutate continuously, resulting in the generation-specific derivative lineages. Since there is no 
recombination of mtDNA, although the lineages are still accumulating and mutating gradually in their own evolution 
process, the lineages that already exist among the lineages are still existing. The phylogenetic relationship is not affect-
ed by the subsequent demography of the population in which it is located. Therefore, there is a theoretical evolutionary 
link between the mtDNA lineages in modern populations. It is possible to reconstruct the phylogenetic relationships of 
matrilineal lineages in a region or even in the world population. The phylogenetic tree (hereinafter referred to as "phy-
logenetic tree") is the most possible true reflection of the evolutionary relationships and evolutionary processes of vari-
ous lineages existing in a population
[14]
. Group history can also help people understand and study diseases related to 
mtDNA mutation. 
2. Application of phylogenetic analysis in mitochondrial genetic diseases 
The ultimate goal of studying the phylogenetic relationship of mtDNA is not only to reconstruct the phylogenetic 
tree, but also to study the population relationship, population dynamics and the correlation between mutation and dis-
ease in a certain area through the mtDNA phylogenetic tree
[15]
. The mitochondrial phylogenetic tree has been widely 
connected in the field of human population genetics. Many studies on mitochondrial diseases do not or seldom refer to 
and use phylogenetic analysis as an effective method, which has two adverse consequences: one is the lack of quality 
detection of mtDNA mutation data. Secondly, the absence of phylogenetic relationships as a background for reference 
analysis makes it easy to look at mutations in mtDNA in isolation, resulting in false positive results or failure to reveal 
true pathogenic mutations. 
2.1 MtDNA family tree in detecting data errors 
There is every reason to doubt the authenticity and credibility of the results of this study for a batch of data with 
quality problems, no matter how fancy the subsequent analysis methods and how perfect the logic of the argument are. 
There are many data quality problems in the research area
[11,12]
, which directly leads to many research results in the field 
can not be duplicated and many views are controversial and so on. One of the ideas they follow is the analysis of phy-
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logenetics. Based on this idea, the following is a summary of our previous work. 
When we analyze the sequence data of mtDNA, we should first take the revised Cambridge reference sequence 
(rCRS)
[19]
 as a reference, and output the mutations in the sequence as mutation sites. Then we should inspect the quality 
of this batch of data, first we should observe whether there is a large number of sparse in the sequence. Previous large 
numbers of human mtDNA sequence information indicated that the frequency of transition in mtDNA was much higher 
than that of tran svers ion. Base tran svers ion was relatively rare compared with tran svers ion, and the mutation to G 
was the rarest
[20–25]
. More rare transmutations were observed in the 560 sequences reported by Herrnstadt et al.
[26]
, in-
cluding more G transmutations, and the larger of these mutations. Some of them were proved to be caused by human or 
sequence errors after re-experiment by the original author
[27]
. Secondly, phylogenetic analysis of the sequences was car-
ried out. Individuals were divided into haplotype groups, that is, under the guidance of lineage trees, all individuals 
were divided into corresponding groups by comparing the same or similar variations among sequences. In theory, each 
copy of mtDNA has its place in the mtDNA lineage tree worldwide. At present, the backbone and branches of the mito-
chondrial lineage tree worldwide (especially in East Asia and Europe) have been basically clear and cannot be classified 
as an individual due to the emergence of a large number of complete mitochondrial sequences. Systemic status is rare. 
After determining the individual's phylogenetic status, any mutation that contradicts the motif of the haplotype group 
must be confirmed by another experiment if a rare mutation is present at different sites. Multiple occurrences in the in-
herited background (i. e. haplotype groups) mean that the mutation may be questionable. This is because mtDNA is ma-
ternal inheritance, lack of recombination, and mutations in evolutionary events are generally considered to follow the 
principle of minimalism, so rare mutations may be wrong in multiple lineages. It is absolutely necessary to obtain 
high-quality data to clearly reveal potential pathogenic mutations, to re-check and even re-sequence the gel map for 
observed rare mutations or any other suspected mutations
[28]
. Conflicting with the variation pattern of another fragment, 
there may be an artificial recombination in which two or more different haplotypes of mtDNA fragments are mixed in a 
sequence. In this case, the experiment (including PCR amplification and DNA sequencing) will be re-validated. The 
incompatibility between mutations of an individual may be caused by frequent mutations or human errors, and judg-
ment of the problem needs to be re-carried out. Finally, for the system tree constructed on the basis of the obtained data, 
any sites with frequent mutation events should be re-sequenced even in the individual rare or private mutation at the top. 
To re test to confirm
[8]
. 
Yao et al.
[29]
 examined a batch of mtDNA data published by Silva et al.
[30]
 on Am J Hum Genet using the above 
method and found many problems and errors. At the same time, six possible causes of these problems and errors were 
summarized in order to prevent the recurrence of similar problems in future research work. The suggestion of Ao et 
al.
[29]
 re-experimentally analyzed the data, confirming and correcting the problems and errors pointed out by Yao et 
al.
[29]
 in the data. This example fully demonstrates the practicability and reliability of phylogenetic analysis for data 
quality detection. 
2.2 MtDNA genealogy and genetic diseases 
Previous studies have found that the vast majority of mutations in mtDNA are neutral
[31,32]
, and only a few are 
harmful. Because of their different harmfulness and other related factors, the distribution of these mutations in the line-
age trees we acquire will show a certain pattern: at the base of the mitochondrial lineage tree. Ancient and subancient 
mutations can be considered at least selective neutral because they have undergone tens of thousands of years of selec-
tive stress. Severe deleterious mutations can cause multiple system dysfunction, leading to very serious disease in pa-
tients. Individuals with such mutations are often unable to survive into adulthood. Thus this mutation can only exist in 
the form of rare mutations in different individuals and is quickly eradicated, not retained in lineages (e. g. 3243 muta-
tion)
[33]
. Medium or late stages of the mutation exhibit pathogenicity and have little effect on the growth of the individ-
ual. The weaker selectivity of the mutation makes it possible for the mutation to exist in a limited number of generations 
and may therefore be polymorphic in the population
[31,33]
; and in some special cases, the mutation may occur in the 
population. There is a certain degree of diffusion. 
Based on the above inference, we can theoretically make a preliminary judgment on the pathogenicity of the re-
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ported mtDNA mutation. If a specific coding region mutation is found in the mtDNA of a patient with a maternal ge-
netic disease, the mutation can be preliminarily classified as a class by detecting a normal individual belonging to the 
same haplotype group. For example, Kong et al.
[35]
 found a T12338C mutation in Chinese studies that led to the loss of 
the starting codon of the mtDNA-ND5 gene (i. e. the translation of the starting amino acid from methionine to threo-
nine), so it looked like a serious pathogenic mutation. According to a comprehensive analysis of 3 000 individuals from 
all over the country, the mutation T12338C caused the loss of the initial codon of the mtDNA ND5 gene, but as one of 
the characteristic mutations in the F2 group, the mutation occurred about 42, 000 years ago and was widely distributed 
among the general population of China (although the frequency was low), and it is now combined with No Association 
of F2 with mtDNA genetic diseases has been reported. The above evidence suggests that T12338C is unlikely to be a 
pathogenic mutation. 
With detailed phylogenetic knowledge as the background, false positive results can be effectively avoided by iso-
lating mutation sites. Because of the frequent migration and communication among modern populations, the genetic 
structure within populations is often very complex, and even populations living in the same region may have different 
genetic backgrounds. Composition of subpopulations, together with the unique genetic characteristics of mtDNA, i. e. 
the distinct mutations carried by different lineages and the strict non-recombination between them, makes it very in-
convenient for the case-control method commonly used in genetic disease research. For example, a family with mito-
chondrial genetic diseases, all of which are maternal inheritance The patient's mtDNA belongs to the same haplotype, 
and the haplotype lineage has its own mutation. In this study, normal people from the same area were selected as con-
trols, and it is likely that these controls belong to other haplotype groups, so there is no mutation site shared with the 
patient's haplotype. In this case, the patient's specific mutation site For example, Tzen et al.
[36]
 found a mutation of 
A14693G in the mtDNA of patients with MELAS and thought it was associated with the disease. However, by analyz-
ing the reconstructed East Asian mtDNA lineage tree, Bandelt et al.
[37]
 found that the mutation was one of the charac-
teristic sites of group Y. However, the population is widespread among the normal population in East Asia, suggesting 
that the mutation is more likely to be normal. 
In addition, detailed phylogenetic knowledge can also be used as a background to avoid false positive or false neg-
ative results in association analysis resulting from population stratification. For example, the mitochondrial haplotype 
groups B, F, R9b, M7b are more abundant in southern China, while the haplotype groups A, C, D, G, M8a, Y, Z are 
more abundant in northern China, but if the southern population studied is moved from the northern China, the hidden 
stratification interference can not be completely eliminated. In the course of the study, if one does not understand the 
possible genetic structure differences caused by this migration event and selects such a population as a control group, 
one can draw some false positive conclusions about disease-related haplotype groups. Understanding the actual mater-
nal genetic structure of populations on various continents and understanding the population relationship and population 
dynamics in a region can effectively assess or avoid the bias caused by population stratification
[8]
. 
Thus, any hasty conclusions or conjectures based solely on rough case-control or statistical tests when studying 
disease-related mtDNA mutations, without judging the molecular basis of the mutation through knowledge of mtDNA 
phylogeny and validating its pathogenicity through population data, can be drawn. Kong et al.
[8,18]
 constructed a com-
prehensive and fine East Asian mtDNA phylogenetic tree by analyzing more than 1000 mtDNA whole genome se-
quences. The detailed phylogenetic tree and the author's suggestions on how to identify pathogenic mutations or mater-
nal genetic backgrounds are all very good for mitochondrial inheritance. It provides reference and help for disease re-
search. 
3. Summary 
The whole genome of mtDNA has developed rapidly in the past few years, and a great deal of research results 
have been made. The whole genome sequence of mtDNA provides the highest molecular resolution. With the increase 
and improvement of the quantity and quality of the whole sequence data, the mtDNA lineage tree of the world popula-
tion will become more complete. Reliable phylogenetic trees can help people understand the evolution of mtDNA muta-
tions and thus help to study genetic diseases more effectively. 
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